Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
Uveitis: Fundamentals and Clinical Practice
This new edition expands on the diagnostic and therapeutic approaches to uveitis with 79 colour photographs, and is even more thorough in its coverage of the medical, pharmacological, and surgical treatment of Uveitis.
DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS
Treatment with dexamethasone intravitreal implant led to statistically and clinically significant improvements in both vision and vascular leakage from diabetic macular edema in difficult-to-treat vitrectomized eyes and had an acceptable safety profile.
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.
In eyes with persistent DME, treatment with 700 microg of intravitreal dexamethasone DDS is well tolerated and produces significant improvements in BCVA, central retinal thickness, and fluorescein leakage compared with observation.
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
- M. Stern, Jian-ping Gao, Janine A. Smith
- Medicine, BiologyInvestigative Ophthalmology and Visual Science
- 1 August 2002
The authors' findings indicate that patients with Sjögren's syndrome keratoconjunctivitis sicca or NS-KCS have conjunctival inflammation manifested by inflammatory cell infiltrates and upregulation of expression in markers of immune activation.
Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity.
Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
The occurrence of PCNSL in the eye was strongly associated with elevated vitreous levels of IL-10 relative to levels ofIL-6, and among patients with diagnosedPCNSL, malignant cells were significantly more likely to be present in CSF when levels of Il-10 exceeded those of IL -6.